Loading...

Zimmer Biomet Holdings, Inc.

ZIM.DEXETRA
HealthcareMedical - Equipment & Services
$94.94
$-0.38(-0.40%)

Zimmer Biomet Holdings, Inc. (ZIM.DE) Stock Overview

Explore Zimmer Biomet Holdings, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
3.85%
3.85%
Profit Growth
$1.38
11.74%
EPS Growth
$1.38
9.37%
Operating Margin
19.02%
0.63%
ROE
2.92%
11.74%
Dividend Yield
0.00%
0.25%
Analyst Recommendations data is not available for ZIM.DEAnalyst Recommendations details for ZIM.DE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare services. The company is headquartered in Warsaw Indiana, Indiana and currently employs 19,000 full-time employees. The firm's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The firm manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The firm's product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.

CEO

Mr. Bryan Hanson

Employees

19,900

Headquarters

345 E Main St, Warsaw Indiana, INDIANA

Founded

2001

Frequently Asked Questions

Meyka LogoMeyka

Meyka is the best Alternative Data platform powered by AI providing research insights for investors

Connect With Us

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

© 2025 Meyka AI PTY LTD. All rights reserved.